Interaction between ß-Adrenergic Receptor Stimulation and Nitric Oxide Release on Tissue Perfusion and Metabolism1
Jens Jordan,
Jens Tank,
Mandy Stoffels,
Gabriele Franke,
Niels Juel Christensen,
Friedrich C. Luft and
Michael Boschmann
Clinical Research Center, Franz Volhard Clinic, Max Delbrück
Center, Medical Faculty of the Charité, Humboldt University
(J.J., J.T., M.S., G.F., F.C.L.), 13125 Berlin, Germany; German
Institute of Human Nutrition (M.B.), 14558 Potsdam, Germany; and
Department of Internal Medicine and Endocrinology, Herlev Hospital,
University of Copenhagen (N.J.C.), 2730 Copenhagen, Denmark
Address all correspondence and requests for reprints to: Jens Jordan, M.D., Clinical Research Center, Franz Volhard Clinic, Humboldt University, Wiltbergstrasse 50, 13125 Berlin, Germany.
Abstract
Nitric oxide (NO) may be an important modulator of sympathetictone. We
used im and sc microdialysis in humans to characterizethe interaction
of NO synthase inhibition and adrenoreceptorstimulation on tissue
perfusion, metabolism, and norepinephrinerelease. Microdialysis probes
were perfused with L- or
D-nitro-L-arginine-methyl-ester(100 µmol/L)
followed by incremental doses of isoproterenol,epinephrine, or
nitroprusside. Blood flow was estimated basedon the ethanol dilution
technique. In muscle, the increase inblood flow with isoproterenol was
abolished by L-NAME. The ethanolratio was 0.03 ±
0.011 with D-NAME and 0.075 ±0.014 with
L-NAME during isoproterenol treatment (1
µmol/L).The effect was less pronounced in adipose
tissue. The vasodilatoryeffect of nitroprusside was similar with
D- and L-NAME. L-NAMEaugmented
isoproterenol- and epinephrine-induced glycerol release.Dialysate
glycerol during 1 µmol/L isoproterenol was 47± 6.7 µmol/L
with D-NAME and 72 ± 15 µmol/Lwith
L-NAME. In skeletal muscle, dialysate norepinephrine during
1µmol/L isoproterenol treatment was 0.73 ± 0.17and 1.3
± 0.15 nmol/L with D- and L-NAME,
respectively.We conclude that NO synthase inhibition attenuates
ß2-adrenoreceptor-mediatedvasodilation and enhances
ß-adrenoreceptor-mediatedlipolysis. These effects are in part
mediated through an increasein interstitial norepinephrine
concentrations. The data areconsistent with the idea that in humans,
NO is important inmodulating and ameliorating sympathetic effects in
peripheraltissues.
This article has been cited by other articles:
M. Boschmann, S. Engeli, K. Dobberstein, P. Budziarek, A. Strauss, J. Boehnke, F. C. G. J. Sweep, F. C. Luft, Y. He, J. E. Foley, et al. Dipeptidyl-Peptidase-IV Inhibition Augments Postprandial Lipid Mobilization and Oxidation in Type 2 Diabetic Patients
J. Clin. Endocrinol. Metab.,
March 1, 2009;
94(3):
846 - 852.
[Abstract][Full Text][PDF]
S. Engeli, M. Boschmann, F. Adams, G. Franke, K. Gorzelniak, J. Janke, F. C. Luft, and J. Jordan Dissociation between Adipose Nitric Oxide Synthase Expression and Tissue Metabolism
J. Clin. Endocrinol. Metab.,
July 1, 2007;
92(7):
2706 - 2711.
[Abstract][Full Text][PDF]
A. L. Birkenfeld, M. Boschmann, C. Moro, F. Adams, K. Heusser, J. Tank, A. Diedrich, C. Schroeder, G. Franke, M. Berlan, et al. {beta}-Adrenergic and Atrial Natriuretic Peptide Interactions on Human Cardiovascular and Metabolic Regulation
J. Clin. Endocrinol. Metab.,
December 1, 2006;
91(12):
5069 - 5075.
[Abstract][Full Text][PDF]
S. Engeli, M. Boschmann, P. Frings, L. Beck, J. Janke, J. Titze, F. C. Luft, M. Heer, and J. Jordan Influence of Salt Intake on Renin-Angiotensin and Natriuretic Peptide System Genes in Human Adipose Tissue
Hypertension,
December 1, 2006;
48(6):
1103 - 1108.
[Abstract][Full Text][PDF]
G. K. McConell, N. N. Huynh, R. S. Lee-Young, B. J. Canny, and G. D. Wadley L-Arginine infusion increases glucose clearance during prolonged exercise in humans
Am J Physiol Endocrinol Metab,
January 1, 2006;
290(1):
E60 - E66.
[Abstract][Full Text][PDF]
M. Boschmann, S. Engeli, F. Adams, G. Franke, F. C. Luft, A. M. Sharma, and J. Jordan Influences of AT1 receptor blockade on tissue metabolism in obese men
Am J Physiol Regulatory Integrative Comp Physiol,
January 1, 2006;
290(1):
R219 - R223.
[Abstract][Full Text][PDF]
M. Boschmann, S. Engeli, F. Adams, K. Gorzelniak, G. Franke, S. Klaua, U. Kreuzberg, S. Luedtke, R. Kettritz, A. M. Sharma, et al. Adipose Tissue Metabolism and CD11b Expression on Monocytes in Obese Hypertensives
Hypertension,
July 1, 2005;
46(1):
130 - 136.
[Abstract][Full Text][PDF]
A. L. Birkenfeld, M. Boschmann, C. Moro, F. Adams, K. Heusser, G. Franke, M. Berlan, F. C. Luft, M. Lafontan, and J. Jordan Lipid Mobilization with Physiological Atrial Natriuretic Peptide Concentrations in Humans
J. Clin. Endocrinol. Metab.,
June 1, 2005;
90(6):
3622 - 3628.
[Abstract][Full Text][PDF]
S. Engeli, J. Janke, K. Gorzelniak, J. Bohnke, N. Ghose, C. Lindschau, F. C. Luft, and A. M. Sharma Regulation of the nitric oxide system in human adipose tissue
J. Lipid Res.,
September 1, 2004;
45(9):
1640 - 1648.
[Abstract][Full Text][PDF]
C. Schroeder, F. Adams, M. Boschmann, J. Tank, S. Haertter, A. Diedrich, I. Biaggioni, F. C. Luft, and J. Jordan Phenotypical evidence for a gender difference in cardiac norepinephrine transporter function
Am J Physiol Regulatory Integrative Comp Physiol,
May 1, 2004;
286(5):
R851 - R856.
[Abstract][Full Text][PDF]
J. Tank, A. Diedrich, E. Szczech, F. C. Luft, and J. Jordan {alpha}-2 Adrenergic Transmission and Human Baroreflex Regulation
Hypertension,
May 1, 2004;
43(5):
1035 - 1041.
[Abstract][Full Text][PDF]
J.-L. Ardilouze, B. A. Fielding, J. M. Currie, K. N. Frayn, and F. Karpe Nitric Oxide and {beta}-Adrenergic Stimulation Are Major Regulators of Preprandial and Postprandial Subcutaneous Adipose Tissue Blood Flow in Humans
Circulation,
January 6, 2004;
109(1):
47 - 52.
[Abstract][Full Text][PDF]
M. Boschmann, J. Steiniger, U. Hille, J. Tank, F. Adams, A. M. Sharma, S. Klaus, F. C. Luft, and J. Jordan Water-Induced Thermogenesis
J. Clin. Endocrinol. Metab.,
December 1, 2003;
88(12):
6015 - 6019.
[Abstract][Full Text][PDF]
M. Boschmann, J. Jordan, F. Adams, N.-J. Christensen, J. Tank, G. Franke, M. Stoffels, A. M. Sharma, F. C. Luft, and S. Klaus Tissue-Specific Response to Interstitial Angiotensin II in Humans
Hypertension,
January 1, 2003;
41(1):
37 - 41.
[Abstract][Full Text][PDF]
M. Boschmann, C. Schroeder, N. J. Christensen, J. Tank, G. Krupp, I. Biaggioni, S. Klaus, A. M. Sharma, F. C. Luft, and J. Jordan Norepinephrine Transporter Function and Autonomic Control of Metabolism
J. Clin. Endocrinol. Metab.,
November 1, 2002;
87(11):
5130 - 5137.
[Abstract][Full Text][PDF]
M. L. Hijmering, E. S. G. Stroes, J. Olijhoek, B. A. Hutten, P. J. Blankestijn, and T. J. Rabelink Sympathetic activation markedly reduces endothelium-dependent, flow-mediated vasodilation
J. Am. Coll. Cardiol.,
February 20, 2002;
39(4):
683 - 688.
[Abstract][Full Text][PDF]
J. Tank, A. Diedrich, C. Schroeder, M. Stoffels, G. Franke, A. M. Sharma, F. C. Luft, and J. Jordan Limited Effect of Systemic {beta}-Blockade on Sympathetic Outflow
Hypertension,
December 1, 2001;
38(6):
1377 - 1381.
[Abstract][Full Text][PDF]